Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
Upcoming Clinical Trials
-
NCT05389124Not yet recruitingConditions: Gingivitis, Oral Disease
-
NCT05389163Not yet recruitingConditions: Class V Dental Caries
-
NCT05389176Not yet recruitingConditions: Septic Shock, Tachycardia
-
NCT05389189Not yet recruitingConditions: Rheumatoid Arthritis
-
NCT05389202RecruitingConditions: Prostate Cancer
-
NCT05389215Not yet recruitingConditions: Idiopathic Pulmonary Fibrosis
-
NCT05389228RecruitingConditions: Atrial Fibrillation, Burden
-
NCT05389241Not yet recruitingConditions: Laparoscopy, Augmented Reality, Orientation, Spatial, Liver
-
NCT05389254Not yet recruitingConditions: Type 2 Diabetes Mellitus, Acute Coronary Syndrome
-
NCT05389267Not yet recruitingConditions: Glaucoma, Ocular Hypertension
Recent CRA jobs
-
Drug Safety Associate (Spain)
-
Project Manager (Early Phase - Clinical Trial)
-
Associate Clinical Trial Project Manager (Early Phase)
-
Project Manager (Clinical - Early Phase)
-
Senior Director, IT Clinical Development
-
Qualified Person for Pharmacovigilance (Temp Contract)
-
Manager / Senior Manager, Clinical Data Engineering
-
Senior Regulatory Affairs Strategy Consultant - Program Lead
-
Engineering Manager
-
Director, Integrated Solutions - Immunology/Infectious Disease